E2 ModerateModerate confidencePEM unclearObservationalPeer-reviewedMachine draft
Parasympathetic activity is reduced during slow-wave sleep, but not resting wakefulness, in patients with chronic fatigue syndrome.
Fatt, Scott J, Beilharz, Jessica E, Joubert, Michael et al. · Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2020 · DOI
Quick Summary
This study found that people with ME/CFS have reduced calming nervous system activity during deep sleep, compared to healthy people. This overactive state during sleep—even when the brain should be resting—is linked to poor sleep quality and feeling unwell. The findings suggest that the body's inability to fully relax during sleep may be a key problem in ME/CFS.
Why It Matters
Unrefreshing sleep is a core symptom of ME/CFS, and this study identifies a specific neurophysiological mechanism—autonomic hypervigilance during deep sleep—that may explain why patients feel unrestored. Understanding this mechanism could guide new therapeutic interventions targeting sleep restoration in ME/CFS.
Observed Findings
- Patients with CFS showed reduced normalized high-frequency HRV (parasympathetic marker) during slow-wave sleep compared to controls.
- CFS patients had slower sleep onset, more awakenings during the night, and spent a larger proportion of time in slow-wave sleep.
- Poorer sleep quality and self-reported wellbeing were associated with reduced parasympathetic activity specifically during deep sleep stages.
- Parasympathetic activity during wakefulness, REM sleep, or the amount of slow-wave sleep did not correlate with wellbeing measures.
Inferred Conclusions
- Autonomic hypervigilance during the deeper, restorative stages of sleep characterizes CFS and may underlie the symptom of unrefreshing sleep.
- Parasympathetic nervous system dysfunction during deep sleep—rather than overall sleep architecture changes—is the key correlate of poor wellbeing in CFS.
- Targeting parasympathetic activity during sleep may represent a potential therapeutic approach for improving sleep quality in CFS.
Remaining Questions
- Does reducing autonomic hypervigilance during sleep (through therapeutic intervention) actually improve sleep quality and wellbeing in CFS patients?
- What mechanisms drive the loss of parasympathetic tone during deep sleep in CFS—is it central nervous system dysregulation, persistent inflammatory signaling, or another process?
What This Study Does Not Prove
This study does not establish causation; reduced parasympathetic activity during sleep may be a consequence rather than a cause of poor sleep quality and wellbeing in ME/CFS. The cross-sectional design cannot determine whether correcting parasympathetic dysfunction would improve symptoms. Additionally, findings may not generalize to all ME/CFS patients or to different disease stages.
Tags
Symptom:Unrefreshing SleepFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleStrong Phenotyping
Metadata
- DOI
- 10.5664/jcsm.8114
- PMID
- 31957647
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →